FDA
approval
· 2021-04-13
FDA Approved: XIAFLEX — Supplemental Application (Endo USA, Inc.)
Summary
FDA approved a supplemental application for Xiaflex (collagenase clostridium histolyticum) submitted by Endo USA, Inc. The approval expands the regulatory autho…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for XIAFLEX (COLLAGENASE CLOSTRIDIUM HISTOLYTICUM)